Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Interest Expense : $-18.46 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Lotus Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lotus Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was $ -4.77 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-18.46 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lotus Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was $ 39.59 Mil. Lotus Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was $ -4.77 Mil. Lotus Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 8.29. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lotus Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Lotus Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lotus Pharmaceutical Co Interest Expense Chart

Lotus Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-11.58

-11.84

-10.70

-12.48

-17.84

Lotus Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-4.20	-4.39	-4.25	-5.05	-4.77

Lotus Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.46 Mil.

Lotus Pharmaceutical Co (OTCPK:LTPCF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lotus Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was $-4.77 Mil. Its Operating Income for the three months ended in Mar. 2024 was $39.59 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $304.05 Mil.

Lotus Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	39.59	/	-4.774
	=	8.29

The higher the ratio, the stronger the company's financial strength is.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lotus Pharmaceutical Co Ltd (OTCPK:LTPCF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

1795:Taiwan

Address

Song Ren Road, 17th Floor, No. 277, Xin Yi District, Taipei, TWN, 110

Website

https://www.lotuspharm.com.tw

Lotus Pharmaceutical Co Ltd is engaged in the healthcare sector. It is engaged in generic drug business segment, which engages mainly in the research and development, manufacturing and sales of generic pharmaceutical products. It has its geographic presence in United States, South Korea and Others.

Lotus Pharmaceutical Co (Lotus Pharmaceutical Co) Headlines

From GuruFocus

LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY

By PRNewswire PRNewswire • 11-11-2022